Resolution of liver biopsy alterations in three siblings with bile acid treatment of an inborn error of bile acid metabolism (Δ4‐3‐oxosteroid 5β‐reductase deficiency)

Ynthia C. Daugherty, Kenneth D. R. Setchell, James E. Heubi, William F. Ballstreri – 1 November 1993 – Identical male twins and their brother, cholestatic from birth, with Δ4‐3‐oxosteroid 5δ‐reductase deficiency, were studied by serial liver biopsy. Spectrometry documented defective primary bile acid synthesis and markedly increased levels of atypical oxo and allo bile acids in urine and serum. Hepatocellular cholestásis and giant‐cell transformation resolved in parallel with clinical and biochemical recovery during oral bile acid administration.

Induction of metallothionein and its localization in the nucleus of rat hepatocytes after partial hepatectomy

Chiharu Tohyama, Junko Sayato Suzuki, Jack Hemelraad, Noriko Nishimura, Hisao Nishimura – 1 November 1993 – Metallothioneins, a group of cysteine‐rich heavymetal binding proteins, are induced in the regenerating rat liver in response to the stimuli evoked by partial hepatectomy. We have investigated the expression of metallothionein genes and proto‐oncogenes (c‐fos, c‐jun and c‐myc), as well as specific localization of metallothionein in the liver cells after partial hepatectomy. Metallothionein mRNA was detected as early as 3 hr and reached a maximal level by 6 hr.

Inhibitory effect of gastrin and cholecystokinin fragments on the secretion of triacylglycerol in rat hepatocytes

Marie Lindholm, Anders Eklund – 1 November 1993 – In this investigation we studied the influence of two gastrin fragments, pentagastrin and nonsulfated heptadecagastrin, and two cholecystokinin fragments, sulfated and desulfated cholecystokinin 26–33, on intracellular and secreted triacylglycerol in isolated hepatocyte cultures. Both gastrin fragments inhibited triacylglycerol release in a biphasic manner, exhibiting maximal effect at 0.1 nmol/L (nonsulfated heptadecagastrin) and 0.3 nmol/L (pentagastrin).

HLA B44–restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein

Hiroto Kita, Takashi Moriyama, Takashi Kaneko, Ichiro Harase, Masayuki Nomura, Hideaki Miura, Ikuo Nakamura, Yoshio Yazaki, Michio Imawari – 1 November 1993 – Cytotoxic T lymphocytes have been reported to be involved in the immune clearance of virus‐infected cells and in the pathogenesis of viral infection. We studied the cytotoxic T lymphocyte response to the putative nucleocapsid protein of hepatitis C virus in patients with chronic hepatitis C.

Positron‐emission tomographic localization of abnormalities of brain metabolism in patients with minimal hepatic encephalopathy

Alan H. Lockwood, Brian W. Murphy, Kerry Z. Donnelly, Thomas C. Mahl, Sean Perini – 1 November 1993 – Many patients with compensated cirrhosis without overt hepatic encephalopathy have deficits in visualspatial perception, a condition we call minimal hepatic encephalopathy. Five patients with alcohol‐induced cirrhosis and nine control subjects underwent positron‐emission tomographic imaging of the brain with 18F‐fluorodeoxyglucose. Patients also underwent neuropsychological and clinical chemistry tests.

Reduction of variceal pressure by propranolol: Comparison of the effects on portal pressure and azygos blood flow in patients with cirrhosis

Faust Feu, Josep María Bordas, Angelo Luca, Joan Carles García‐Pagán, Angels Escorsell, Jaume Bosch, Joan Rodes – 1 November 1993 – This study investigated the correlation between changes in hepatic hemodynamics and esophageal variceal pressure–measured with a noninvasive, pressure‐sensitive endoscopic gauge–in 37 portal‐hypertensive cirrhotic patients receiving propranolol (0.15 mg/kg, intravenously; n = 21) or placebo (n = 16) under strict double‐blind conditions. Placebo administration had no effect on hepatic venous pressure gradient, azygos blood flow or variceal pressure.

Treatment of small hepatocellular carcinoma in cirrhotic patients: A cohort study comparing surgical resection and percutaneous ethanol injection

Antoni Castells, Jordi Bruix, Concepció Bru, Josep Fuster, Ramon Vilana, Miquel Navasa, Carmen Ayuso, Loreto Boix, Josep Visa, Joan Rodés – 1 November 1993 – This study was intended to compare the survival rates of two contemporary cohorts of patients with solitary hepatocellular carcinomas ≤ 4 cm subjected to surgical resection (n = 33) or percutaneous ethanol injection (n = 30). Outcomes in a third cohort, 21 patients with hepatocellular carcinoma who underwent orthotopic liver transplantation, were also assessed.

Experimental evidence that the physiological position of the liver within the circulation is not a major determinant of zonation of gene expression

Gerry T. M. Wagenaar, Robert A. F. M. Chamuleau, Jan G. de Haan, Martinus A. W. Maas, Piet A. J. de Boer, Frans Marx, Antoon F. M. Moorman, Wilma M. Frederiks, Wouter H. Lamers – 1 November 1993 – Many enzymes are distributed heterogeneously within the liver lobule. The factors that play a determining role in the establishment and maintenance of these heterogeneous expression patterns have not yet been identified.

Oxygen free radical production mediated by cocaine and its ethanol‐derived metabolite, cocaethylene, in rat hepatocytes

Urs A. Boelsterli, Armin Wolf, Christian Göldlin – 1 November 1993 – Cocaine ethyl ester (“cocaethylene”) is a cocaine metabolite formed by hepatic carboxylesterases in the presence of ethanol. In the human liver, this pharmacologically active cocaine analog may reach concentrations similar to those of cocaine.

Subscribe to